KA
CANO

Kerrisdale Advisers’s Cano Health, Inc. CANO Stock Holding History

Kerrisdale Advisers’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,767
Closed -$9.85M – 62
2021
Q3 		$9.85M Sell
7,767
-3,530
-31% -$4.28M 1.07% 30
2021
Q2 		$13.7M Buy
11,297
+1,047
+10% +$1.41M 1.23% 32
2021
Q1 		$13.6M Buy
10,250
+5,301
+107% +$7.51M 1.04% 32
2020
Q4 		$6.64M Buy
+4,949
New +$5.66M 0.51% 44

Other funds holding CANO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Kerrisdale Advisers's CANO Position: Q4 2021 in Review

Kerrisdale Advisers sold out of Cano Health, Inc. (CANO) in Q4 2021, closing a stake of 7,767 shares — an estimated $9.85M sold.

Kerrisdale Advisers first reported a position in CANO in Q4 2020 and held it in 4 quarters. The position peaked at $13.7M in Q2 2021. 130 funds tracked by Wall St. Rank hold CANO as of Q4 2021.

  • Kerrisdale Advisers reported no remaining Cano Health, Inc. position as of Q4 2021 after selling out during the quarter.
  • Kerrisdale Advisers sold 7,767 Cano Health, Inc. shares in Q4 2021, an estimated $9.85M.
  • Kerrisdale Advisers first reported a position in Cano Health, Inc. in Q4 2020 and held it in 4 quarters.
  • Kerrisdale Advisers's Cano Health, Inc. position peaked at $13.7M in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2021.

Based on Kerrisdale Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.